Changeflow GovPing Pharma & Drug Safety Composition for Promoting the Skin Microbiome
Routine Notice Added Draft

Composition for Promoting the Skin Microbiome

Favicon for changeflow.com ChangeBridge: Patent Apps - Pharma (A61K)
Published
Detected
Email

Summary

USPTO published patent application US20260090967A1 for a skin microbiome promoting composition. The application claims a combination of carbon sources (glucose, fructose, saccharose, maltose, maltodextrin, pyruvic acid, pyruvate, lactic acid and lactate) and nitrogen sources (alanine, glycine, arginine and urea), and/or caprylic/capric triglycerides. Inventors include Jennifer Huepeden, Mirja Laschet, Karen Tom Dieck, Heike Foelster, and Sabine Sellckau.

What changed

USPTO published patent application US20260090967A1 for a skin care composition designed to promote healthy skin microbiome development. The composition includes growth-enhancing compounds combining carbon sources (glucose, fructose, saccharose, maltose, maltodextrin, pyruvic acid/pyruvate, lactic acid/lactate) with nitrogen sources (alanine, glycine, arginine, urea) and/or caprylic/capric triglycerides. The application was filed on September 2, 2025, with Application No. 19316136.

This publication represents a routine patent application filing that provides public notice of the claimed invention. No compliance actions are required from market participants. Companies developing skin microbiome or probiotic skincare products may wish to review the claims to assess potential patent landscape considerations.

Archived snapshot

Apr 2, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

COMPOSITION FOR PROMOTING THE SKIN MICROBIOME

Application US20260090967A1 Kind: A1 Apr 02, 2026

Inventors

Jennifer HUEPEDEN, Mirja Laschet, Karen Tom Dieck, Heike Foelster, Sabine SELLCKAU

Abstract

A skin care composition comprises growth-enhancing compounds which promote the development of a healthy skin microbiome and in particular, a carbon source selected from one or moreof glucose, fructose, saccharose, maltose, maltodextrin, pyruvic acid, pyruvate, lactic acid and lactate, and a nitrogen source selected from one or more of alanine, glycine, arginine and urea, and/or caprylic/capric triglycerides.

CPC Classifications

A61K 8/60 A61K 8/365 A61K 8/375 A61K 8/44 A61Q 19/00

Filing Date

2025-09-02

Application No.

19316136

View original document →

Get daily alerts for ChangeBridge: Patent Apps - Pharma (A61K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.

Last updated

Classification

Agency
USPTO
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260090967A1

Who this affects

Applies to
Drug manufacturers Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent Filing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Consumer Protection

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.